Trial Profile
Oxytocin-based pharmacotherapy for Autism Spectrum Disorders: Investigating the neural and behavioral effects of a promising intervention approach
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2018
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 22 Aug 2014 New trial record